Study of Efficacy and Safety of MAS825 in Patients With COVID-19

Clinical trial NCT04382651 · COMPLETED

Trial details

NCT number: NCT04382651
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Pneumonia, Impaired Respiratory Function

Start date: 2020-06-11
Primary completion: 2021-01-06
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.